2024 ISPE Pharma 4.0™ and Annex 1 Conference

Conference Overview

The 2024 ISPE Pharma 4.0™ and Annex 1 Conference will bring together leading pharmaceutical and biopharmaceutical manufacturers, technology providers, academic scientists, and international regulators to network, share insights, and provide an outlook on digital transformation, automation, and the evolving landscape and future of Pharma 4.0™ supported Aseptic Manufacturing.

The conference will provide a leading interdisciplinary platform for all stakeholders of the pharmaceutical chain. These sessions and workshops will showcase recent innovations and trends, and directly discuss practical challenges and solutions, from a technical, logistical, and regulatory perspective. The impact of Quality Risk Management (QRM) and Contamination Control Strategy (CCS) regulations, in particular for Annex 1, will be integrated throughout the conference programme and discussions. Participants will have the opportunity to engage with industry leaders, regulators, and peers through networking events and the conference programme.

Call for Proposals Timeline

  • Submission Opens
  • Submission Deadline
  • Notifications Sent

Submit Proposal 

Abstract submissions may be proposed for the following

  1. Individual Oral Presentation
    • 20-minute presentation, to be made part of a track by the Planning Committee. The presentation should focus on new and innovative trends, a specific real-world strategy or campaign, a case study/use case, or a “how-to" presentation intended to help attendees gain a better understanding of the initiative and best practices that can be applied to day-to-day objectives or overall mission.

Content Areas

The 2024 ISPE Pharma 4.0™ and Annex 1 Conference International Programme Committee are requesting proposals aligning with the following content areas:

Proposal Guidelines

  • All presentations must be free of commercial intent. Incomplete proposals will not be considered.
  • By submitting a proposal, you acknowledge that, if your proposal is accepted, the speaker will attend/present in-person at the event and their organization will support the speaker’s attendance at the event.
  • Accepted speakers are responsible for their own travel and accommodations.
  • Speakers giving at least a 20-minute presentation (not including Q&A) receive complimentary conference registration.
  • NOTE: Exhibitors who are accepted to present are required to register as a paid conference attendee (with discounted registration rate). Complimentary booth staffing registrations cannot be utilized for the presentations as these are part of the education sessions and not the exhibition.
  • Consulting firms or vendors/suppliers are expected to include a speaker from an owner company to present.
  • Regulators interested in submitting a proposal: Please contact Brandy Berry (bberry@ispe.org) to submit your abstract.

Receive Notifications

Stay up-to-date on registration, education opportunities, speakers, hotel discounts, exhibitor information, and more by signing up to receive notifications for the 2024 ISPE Pharma 4.0™ and Annex 1 Conference.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Company Type

Programme Committee

Richard Denk
Senior Consultant Aseptic Processing & Containment
Annex 1 Co-Chair
Line Lundsberg-Nielsen, PhD
Managing Consultant, Compliance Consulting
Pharma 4.0 Co-Chair
Jörg Zimmermann
Vice President Vetter Development Service External Affairs
Vetter Pharma Fertigung GmbH & Co KG
Past Chair
Liz M. Dooley, MSc
Senior Director, Global Engineering & Technology
Johnson & Johnson
International Board Liaison
Nuha Al-Hafez
Quality Fundamentals Area Lead
Thomas Carganico
Vice President Strategic Development, Marketing & Communication - Partner
PQE Group
Yvonne Duckworth, PE
Fellow - Digital Technology, Associate
Jean-François Duliere
Regulatory Advisor
Oliver Herrmann
Managing Director
Q-FINITY Quality Management
Judith Koliwer
Senior Industry Advisor and Principal Consultant for Advanced Therapies
Körber Pharma Software Inc
Teresa Minero
Founder & CEO
LifeBee - Digitalizing Life Sciences
Heike Roeder
Vice President QA International
Edoardo Schiraldi
Corporate Program Manager
Josef Trapl
Managing Director
Memo3 GmbH
Christian Wölbeling
Executive Industry Advisor
Körber Pharma Software GmbH
Placeholder Person Graphic
Isabel Garcia Mora
Quality Assurance Project Manager
Lonza AG
Emerging Leader
Pol Bonet Sune
Project Advisor
Aseptic Mind
Emerging Leader
Stephan Huelber
Process Engineer
VTU Engineering GmbH
Emerging Leader
Maja Karovic
Network Technology Robotics Lead
F Hoffmann-La Roche AG
Emerging Leader
Vinzenz Zauner
PhD Candidate
Vienna University of Technology
Emerging Leader
Laura Kuger
PhD Candidate
Karlsruhe Institute of Technology (KIT)
Emerging Leader